Homoeopathic treatment of Migraine
- Conditions
- Health Condition 1: G439- Migraine, unspecified
- Registration Number
- CTRI/2022/07/044049
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Subjects who has diagnosed as per the International classification of Headache disorders diagnostic criteria - 3 for Migraine.
2. Subjects will be selected irrespective of their sex, socio-economic status and occupation.
3. Age between 18 to 50 years.
4. If the subject is illiterate then the relatives or family members will be assessed to fill the headache diary.
5. Subjects who are willing to participate and sign the written informed consent form.
1. Subjects suffering from the complications of migraine.
2. Suspected secondary headache (trauma, headache attributed to vascular or non vascular intracranial disorders, medication overuse headache, hypertension).
3. Subjects are undergoing treatment with non-steroidal anti inflammatory drugs (NSAIDS), antiemetic, triptans, ergot alkaloids and oestrogen during 2 weeks prior to enrollment in the study.
4. Subjects suffering from uncontrolled systemic illness or psychiatric diseases and/or life-threatening infections.
5. Substance abuse and/or dependence.
6. Pregnant or lactating women.
7. Subjects already undergoing homoeopathic treatment elsewhere for any chronic disease within last 02 months.
8. Non-compliance to the study treatment/ protocol.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diagnostic Headache Diary (DHD)Timepoint: Baseline, every month, up to 6 months
- Secondary Outcome Measures
Name Time Method EQ-5D-5L and EQ-VAS QuestionnaireTimepoint: Baseline, 3 month, 6 months;Migraine Disability Assessment Questionnaire (MIDAS)Timepoint: Baseline, 3 months, 6 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.